Inactive Instrument

MASR PHAR

MPH

PLMSTPH00016

Tranche Update on Master Pharm SA's Equity Buyback Plan announced on June 24, 2020.

April 15, 2021 at 02:26 pm EDT

From October 1, 2020 to December 31, 2020, the company has repurchased 0 shares, representing 0% for PLN 0 million. With this, the company has completed the repurchase of 419,800 shares, representing 1.95% for PLN 1.76 million under the buyback announced on June 24, 2020.

Latest news about MASR PHAR

Farmaceutici Procemsa SPA signed an agreement to acquire an unknown majority stake in Master Pharm SA.	23-08-15	CI
Master Pharm SA's Equity Buyback announced on June 24, 2020, has expired.	23-06-23	CI
Master Pharm SA Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-21	CI
Master Pharm SA announces an Equity Buyback for 2,600,000 shares, for PLN 15.86 million.	22-09-14	CI
Master Pharm SA authorizes a Buyback Plan.	22-09-13	CI
Master Pharm SA Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-13	CI
Master Pharm SA Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-26	CI
Master Pharm SA Reports Earnings Results for the Nine Months Ended September 30, 2021	21-11-19	CI
Master Pharm SA's Equity Buyback announced on October 4, 2021, has expired.	21-10-12	CI
Master Pharm SA announces an Equity Buyback for 1,000,000 shares, for PLN 4.5 million.	21-10-04	CI
Master Pharm SA authorizes a Buyback Plan.	21-10-03	CI
Master Pharm Sa Reports Earnings Results for the Half Year Ended June 30, 2021	21-09-30	CI
Tranche Update on Master Pharm SA's Equity Buyback Plan announced on June 24, 2020.	21-05-17	CI
Master Pharm SA Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-17	CI
Tranche Update on Master Pharm SA's Equity Buyback Plan announced on June 24, 2020.	21-04-15	CI
Master Pharm Sa Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-15	CI
Tranche Update on Master Pharm SA's Equity Buyback Plan announced on June 24, 2020.	20-11-19	CI
Master Pharm Sa Announces Earnings Results for the Nine Months Ended September 30, 2020	20-11-19	CI
Tranche Update on Master Pharm SA's Equity Buyback Plan announced on June 24, 2020.	20-09-24	CI
Master Pharm Sa Reports Earnings Results for the Half Year Ended June 30, 2020	20-09-24	CI
Master Pharm SA announces an Equity Buyback for 4,300,000 shares, for PLN 18.2 million.	20-06-23	CI
An unknown natural person acquired AvetPharma Sp. z o.o. from Master Pharm SA for PLN 1000.	19-12-23	CI
Master Pharm Mulls Potential Acquisitions	18-04-09	CI
Master Pharm SA Withdraws Talks To Acquire Business Of Company Operating In Pharma	17-12-21	CI
Certain Series A Common Shares of Master Pharm SA are subject to a Lock-Up Agreement Ending on 27-APR-2017.	17-04-26	CI

Chart MASR PHAR

Duration

Period

More charts

Company Profile

Master Pharm SA is a Poland-based company primarily engaged in the manufacture of wellbeing products. The Company specializes in designing and producing diet supplements, food for special nutritional purposes, dietary products, cosmetics, medical devices, as well as other consumables for third parties. Its activities are divided into four operating areas: Contract manufacturing, including designing technology and ingredients of products, manufacturing, packaging, labeling, and marking, among others; Preparation of product documentation, providing product specification, certificate of ingredients and technical etiquette; Import-export, trading with raw materials and food supplements, and Medical Devices, offering medical device design, tests, documentation, and registration. The Company cooperates with Adamed, Bioton, Synoptis, Polpharma, Pharmena, and Salvum, among others. The main shareholder of the Company is Max Welt Holdings Ltd.

Sector

Food Processing

More about the company

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
ZHEJIANG NHU COMPANY LTD.	+10.73%	7.96B
BELLRING BRANDS, INC.	+8.44%	7.66B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	-0.58%	5.88B
THE SIMPLY GOOD FOODS COMPANY	-6.11%	3.72B
BYHEALTH CO., LTD	-13.21%	3.47B
XIAMEN KINGDOMWAY GROUP COMPANY	-15.49%	1.16B
SIRIO PHARMA CO., LTD.	+9.98%	948M
USANA HEALTH SCIENCES, INC.	-11.42%	905M
JAMIESON WELLNESS INC.	-13.08%	831M

Special Foods & Wellbeing Products